US Patent Issued to Neuracle Science on Nov. 11 for "Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of glaucoma" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,880, issued on Nov. 11, was assigned to Neuracle Science Co. Ltd. (Seoul, South Korea).

"Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of glaucoma" was invented by Bongcheol Kim (Seongnam-si, South Korea), Dong Sik Kim (Seoul, South Korea) and Soon-gu Kwon (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat a glaucoma in a subject in need thereof."

The patent was filed on July 27, 2023, under Application No. 18/360,143.

*For ...